Dr. Roy Elterman, MD
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Royalty or License | $9.7M | 16 | 100.0% |
| Food and Beverage | $225.36 | 11 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lundbeck LLC | $9.7M | 16 | $0 (2024) |
| ABBVIE INC. | $124.01 | 6 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $64.07 | 3 | $0 (2019) |
| Tris Pharma Inc | $19.37 | 1 | $0 (2019) |
| AQUESTIVE THERAPEUTICS, INC. | $17.91 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $342,443 | 5 | Lundbeck LLC ($342,375) |
| 2023 | $630,654 | 5 | Lundbeck LLC ($630,598) |
| 2022 | $889,133 | 2 | Lundbeck LLC ($889,133) |
| 2021 | $1.0M | 2 | Lundbeck LLC ($1.0M) |
| 2020 | $1.1M | 2 | Lundbeck LLC ($1.1M) |
| 2019 | $1.4M | 5 | Lundbeck LLC ($1.4M) |
| 2018 | $2.1M | 2 | Lundbeck LLC ($2.1M) |
| 2017 | $2.2M | 4 | Lundbeck LLC ($2.2M) |
All Payment Transactions
27 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/23/2024 | Lundbeck LLC | SABRIL (Drug) | Royalty or License | Cash or cash equivalent | $230,686.56 | General |
| Category: NEUROLOGY | ||||||
| 08/16/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 06/25/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $22.01 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 04/24/2024 | Lundbeck LLC | SABRIL (Drug) | Royalty or License | Cash or cash equivalent | $111,688.65 | General |
| Category: NEUROLOGY | ||||||
| 02/26/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $28.03 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/12/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $25.49 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/17/2023 | Lundbeck LLC | SABRIL (Drug) | Royalty or License | Cash or cash equivalent | $285,406.78 | General |
| Category: NEUROLOGY | ||||||
| 10/12/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 07/22/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 04/25/2023 | Lundbeck LLC | SABRIL (Drug) | Royalty or License | Cash or cash equivalent | $345,190.93 | General |
| Category: NEUROLOGY | ||||||
| 10/17/2022 | Lundbeck LLC | SABRIL (Drug) | Royalty or License | Cash or cash equivalent | $434,882.35 | General |
| Category: NEUROLOGY | ||||||
| 06/29/2022 | Lundbeck LLC | SABRIL (Drug) | Royalty or License | Cash or cash equivalent | $454,250.83 | General |
| Category: NEUROLOGY | ||||||
| 10/25/2021 | Lundbeck LLC | SABRIL (Drug) | Royalty or License | Cash or cash equivalent | $481,618.92 | General |
| Category: NEUROLOGY | ||||||
| 04/21/2021 | Lundbeck LLC | SABRIL (Drug) | Royalty or License | Cash or cash equivalent | $539,655.00 | General |
| Category: NEUROLOGY | ||||||
| 10/14/2020 | Lundbeck LLC | SABRIL (Drug) | Royalty or License | Cash or cash equivalent | $586,668.90 | General |
| Category: NEUROLOGY | ||||||
| 04/27/2020 | Lundbeck LLC | SABRIL (Drug) | Royalty or License | Cash or cash equivalent | $529,288.88 | General |
| Category: NEUROLOGY | ||||||
| 10/26/2019 | Lundbeck LLC | SABRIL (Drug) | Royalty or License | Cash or cash equivalent | $542,032.80 | General |
| Category: NEUROLOGY | ||||||
| 08/29/2019 | Tris Pharma Inc | Quillichew ER (Drug) | Food and Beverage | In-kind items and services | $19.37 | General |
| Category: ADHD | ||||||
| 04/22/2019 | Lundbeck LLC | SABRIL (Drug) | Royalty or License | Cash or cash equivalent | $892,938.68 | General |
| Category: NEUROLOGY | ||||||
| 04/16/2019 | Sunovion Pharmaceuticals Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $16.55 | General |
| Category: CNS | ||||||
| 03/07/2019 | AQUESTIVE THERAPEUTICS, INC. | SYMPAZAN (Drug) | Food and Beverage | In-kind items and services | $17.91 | General |
| Category: Neurology | ||||||
| 10/22/2018 | Lundbeck LLC | SABRIL (Drug) | Royalty or License | Cash or cash equivalent | $980,753.02 | General |
| Category: NEUROLOGY | ||||||
| 04/13/2018 | Lundbeck LLC | SABRIL (Drug) | Royalty or License | Cash or cash equivalent | $1,072,045.25 | General |
| Category: NEUROLOGY | ||||||
| 11/30/2017 | Sunovion Pharmaceuticals Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $24.04 | General |
| Category: CNS | ||||||
| 10/27/2017 | Sunovion Pharmaceuticals Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $23.48 | General |
| Category: CNS | ||||||
About Dr. Roy Elterman, MD
Dr. Roy Elterman, MD is a Neurology with Special Qualifications in Child Neurology healthcare provider based in Dallas, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/16/2005. The National Provider Identifier (NPI) number assigned to this provider is 1215913751.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Roy Elterman, MD has received a total of $9.7M in payments from pharmaceutical and medical device companies, with $342,443 received in 2024. These payments were reported across 27 transactions from 5 companies. The most common payment nature is "Royalty or License" ($9.7M).
Practice Information
- Specialty Neurology with Special Qualifications in Child Neurology
- Location Dallas, TX
- Active Since 12/16/2005
- Last Updated 01/11/2011
- Taxonomy Code 2084N0402X
- Entity Type Individual
- NPI Number 1215913751
Products in Payments
- SABRIL (Drug) $9.7M
- BOTOX (Biological) $124.01
- APTIOM (Drug) $64.07
- Quillichew ER (Drug) $19.37
- SYMPAZAN (Drug) $17.91
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology with Special Qualifications in Child Neurology Doctors in Dallas
Raphael Schiffmann, M.d, M.D
Neurology with Special Qualifications in Child Neurology — Payments: $122,917
Mauricio Delgado, M.d, M.D
Neurology with Special Qualifications in Child Neurology — Payments: $99,674
Dr. Steven Sparagana, M.d, M.D
Neurology with Special Qualifications in Child Neurology — Payments: $16,452
Berge Minassian
Neurology with Special Qualifications in Child Neurology — Payments: $5,079
Dr. Deepa Sirsi, Md, MD
Neurology with Special Qualifications in Child Neurology — Payments: $1,867
Charuta Joshi, Mbbs, Md, MBBS, MD
Neurology with Special Qualifications in Child Neurology — Payments: $1,114